A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands

Completed · Phase 1 · Has a placebo group

Conditions studied: Asthma

In brief

The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of the two medications in one inhaler. The purpose of the study is to determine how the medication affects the amount, if any, of cortisol produced by the adrenal glands.

Key facts

Study ID

NCT00657774

Run by

SkyePharma AG

People needed

160

Starts

2008-04-01

Expected to finish

2008-09-01

Last updated by the study team

2008-12-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-65 at the Screening Visit;
• History of asthma for at least 6 months prior to Screening Visit
• Well controlled asthma with rescue short acting beta agonist (albuterol) and or stable doses of other medications for at least 4 weeks prior to Screening Visit
• Female subjects that are not pregnant or lactating
• Otherwise healthy as determined by the Investigator.

You may not qualify if…

• Life-threatening asthma within the past year or visit to emergency room for asthma in the past 3 months prior to the Screening Visit;
• Significant,nonreversible pulmonary disease (e.g. chronic obstructive pulmonary disease, cystic fibrosis or bronchiectasis)
• Use of any steroid medications, topical or inhaled steroids within 4 weeks or systemic (oral or injectable) steroids within 3 months of dosing
• An upper or lower respiratory tract infection within the last 4 weeks pior to Screening Visit or acute illness or infection within 6 weeks prior to dosing
• Any significant disease or major disorder that may jeopardize subject safety
• History of tabacco use within 6 months prior to dosing and/or smoking history > 10 pack-years
• Female subjects on hormone replacement therapy or using birth control involving hormones in the past 6 months
• Additional inclusion and exclusion criteria will evaluated by the investigator.

Where it is running

• Investigational site — Phoenix, Arizona, United States
• Investigational site — Anaheim, California, United States
• Investigational site — Long Beach, California, United States
• Investigational site — San Diego, California, United States
• Investigational site — Centennial, Colorado, United States
• Investigational site — Colorado Springs, Colorado, United States
• Investigational site — Denver, Colorado, United States
• Investigational site — Lakewood, Colorado, United States
• Investigational site — DeLand, Florida, United States
• Investigational Site — Pasadena, Maryland, United States
• Investigational site — North Dartmouth, Massachusetts, United States
• Investigational site — Omaha, Nebraska, United States
• Investigational site — Skillman, New Jersey, United States
• Investigational Site — Lake Oswego, Oregon, United States
• Investigational site — Portland, Oregon, United States
• Investigational site — Spartanburg, South Carolina, United States
• Investigational site — El Paso, Texas, United States
• Investigational site — New Braunfels, Texas, United States
• Investigational site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.